[HTML][HTML] Secreted gelsolin inhibits DNGR-1-dependent cross-presentation and cancer immunity

E Giampazolias, O Schulz, KHJ Lim, NC Rogers… - Cell, 2021 - cell.com
Cross-presentation of antigens from dead tumor cells by type 1 conventional dendritic cells
(cDC1s) is thought to underlie priming of anti-cancer CD8+ T cells. cDC1 express high …

[引用][C] Secreted gelsolin inhibits DNGR-1-dependent cross-presentation and cancer immunity

E Giampazolias, O Schulz, KHJ Lim, NC Rogers… - Cell, 2021 - cir.nii.ac.jp
Secreted gelsolin inhibits DNGR-1-dependent cross-presentation and cancer immunity | CiNii
Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 …

[HTML][HTML] Secreted gelsolin inhibits DNGR-1-dependent cross-presentation and cancer immunity

E Giampazolias, O Schulz, KHJ Lim, NC Rogers… - Cell, 2021 - Elsevier
Cross-presentation of antigens from dead tumor cells by type 1 conventional dendritic cells
(cDC1s) is thought to underlie priming of anti-cancer CD8+ T cells. cDC1 express high …

[HTML][HTML] Secreted gelsolin inhibits DNGR-1-dependent cross-presentation and cancer immunity

E Giampazolias, O Schulz, KHJ Lim, NC Rogers… - Cell, 2021 - ncbi.nlm.nih.gov
Cross-presentation of antigens from dead tumor cells by type 1 conventional dendritic cells
(cDC1s) is thought to underlie priming of anti-cancer CD8+ T cells. cDC1 express high …

Secreted gelsolin inhibits DNGR-1-dependent cross-presentation and cancer immunity

E Giampazolias, O Schulz, KHJ Lim, NC Rogers… - paper.sciencenet.cn
Cross-presentation of antigens from dead tumor cells by type 1 conventional dendritic cells
(cDC1s) is thought to underlie priming of anti-cancer CD8+ T cells. cDC1 express high …

Secreted gelsolin inhibits DNGR-1-dependent cross-presentation and cancer immunity

E Giampazolias, O Schulz, KHJ Lim, NC Rogers… - 2021 - crick.figshare.com
Cross-presentation of antigens from dead tumor cells by type 1 conventional dendritic cells
(cDC1s) is thought to underlie priming of anti-cancer CD8+ T cells. cDC1 express high …

Secreted gelsolin inhibits DNGR-1-dependent cross-presentation and cancer immunity.

E Giampazolias, O Schulz, KHJ Lim, NC Rogers… - Cell, 2021 - europepmc.org
Cross-presentation of antigens from dead tumor cells by type 1 conventional dendritic cells
(cDC1s) is thought to underlie priming of anti-cancer CD8+ T cells. cDC1 express high …

[HTML][HTML] Secreted gelsolin inhibits DNGR-1-dependent cross-presentation and cancer immunity

E Giampazolias, O Schulz, KHJ Lim, NC Rogers… - Cell, 2021 - cell.com
Cross-presentation of antigens from dead tumor cells by type 1 conventional dendritic cells
(cDC1s) is thought to underlie priming of anti-cancer CD8+ T cells. cDC1 express high …

Secreted gelsolin inhibits DNGR-1-dependent cross-presentation and cancer immunity

E Giampazolias, O Schulz, KHJ Lim, NC Rogers… - Cell, 2021 - pubmed.ncbi.nlm.nih.gov
Cross-presentation of antigens from dead tumor cells by type 1 conventional dendritic cells
(cDC1s) is thought to underlie priming of anti-cancer CD8+ T cells. cDC1 express high …

[PDF][PDF] Secreted gelsolin inhibits DNGR-1-dependent cross-presentation and cancer immunity

E Giampazolias, O Schulz, KHJ Lim, NC Rogers… - Cell, 2021 - crick.figshare.com
Cross-presentation of antigens from dead tumor cells by type 1 conventional dendritic cells
(cDC1s) is thought to underlie priming of anti-cancer CD8+ T cells. cDC1 express high …